Fig. 6From: 14,15-Dihydroxyeicosatrienoic acid, a soluble epoxide hydrolase metabolite in blood, is a predictor of anthracycline-induced cardiotoxicity – a hypothesis generating studyIncreased plasma levels of 14,15-DHET (A) or 20-HETE (B) of DOX-treated breast cancer patients. Plasma samples of breast cancer patients were collected before and after 3 months of chemotherapy. Data are presented as mean ± SD. *p < 0.05, triplicate values obtained by ELISA for each patient after chemotherapy compared to before chemotherapy using paired T-testBack to article page